Evidence map›Paper›PMID 41143935›Full record

ArticleIn vitro cellular & developmental biology. Animal2025

Radiotherapy promotes M2 polarization of macrophages through the regulation of the PTEN/PI3K/AKT signaling pathway through miR-616-3p in lung cancer cell-derived exosomes.

Lei Yang, Zhixian Zhang, Yi Zhang, Lijuan Wang, Shuangzhi Zheng, Yongli Li, Decai Du, Changli Yuan, Hongxun Li, Zhi Zeng and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lei Yang *Department of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Zhixian Zhang *Department of Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Yi ZhangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Lijuan WangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Shuangzhi ZhengDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Yongli LiDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Decai DuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Changli YuanDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Hongxun LiDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Zhi ZengDepartment of Nuclear Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China.
Hong LiuDepartment of Thyroid & Breast Surgery, Dali Bai Autonomous Prefecture People's Hospital, Dali, Yunnan, 671000, China. lh@dlzyy.com.cn.
Juntao YangDepartment of Radiology, Dali Bai Autonomous Prefecture People's Hospital, Dali, Yunnan, 671000, China. 13577299815@163.com.

Funding

the Joint Key Project of Science and Technology Department of Yunnan Province and Kunming Medical University 202401AY070001-082
6 · The paper itself

Abstract

Resistance to radiation therapy (RT) poses a significant challenge in managing non-small cell lung cancer (NSCLC). Despite research into how tumor-sourced exosome (Exo) miRNAs influence tumor RT resistance and macrophage M2 polarization, the process through which Exos with miR-616-3p modulate macrophage polarization to impact NSCLC RT resistance is still not well understood. The objective of this research was to investigate the molecular processes by which RT regulates M2 polarization of macrophages via the Exos miR-616-3p derived from NSCLC cells. Identification of Exos was conducted using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). Flow cytometry, immunofluorescence, and ELISA were employed to verify the macrophage phenotype. The expression of miR-616-3p was identified using RT-qPCR, and the targeting relationship between miR-616-3p and PTEN was confirmed through dual-luciferase reporter gene tests and RIP identification. In NSCLC, miR-616-3p showed high expression levels and was linked to RT and M2 polarization in macrophages. Subsequent research indicated that RT prompted the influx of Exos-miR-616-3p from NSCLC cells into macrophages. Both the H1299 lung cancer cell line and the M0 macrophages underwent co-culture. Findings indicated that NSCLC cells induced by RT and Exos elevated the proportion of CD163 + CD206 + positive cells in macrophages via miR-616-3p and augmented Arg1, IL-10, TGF-β1, and VEGF levels, and enhanced M2 polarization in macrophages. Regarding the molecular process, miR-616-3p suppressed PTEN protein expression while concurrently boosting the levels of p-PI3K/PI3K and p-AKT/AKT; either amplifying PTEN or suppressing PI3K could markedly weaken the impact of ionizing radiation (IR), inhibiting the impact of NSCLC cell Exos on macrophages' M2 polarization. This research reveals that in NSCLC cells induced by IR, Exos with miR-616-3p expression reduce PTEN levels and enhance the PI3K/AKT signaling pathway, leading to increased M2 polarization in macrophages and worsening NSCLC progression.

Indexed as

Carcinoma, Non-Small-Cell LungCell PolarityExosomesLung NeoplasmsMacrophagesMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseSignal TransductionAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanExosomesMacrophage polarizationMiR-616-3pNon-small cell lung cancerPTEN/PI3K/AKTRadiotherapy

Identifiers

PMID41143935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.